These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1315940)

  • 1. A highly selective kappa-opioid receptor agonist, CI-977, reduces excitatory synaptic potentials in the rat locus coeruleus in vitro.
    Pinnock RD
    Neuroscience; 1992; 47(1):87-94. PubMed ID: 1315940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of kappa-opioid receptors depresses electrically evoked excitatory postsynaptic potentials on 5-HT-sensitive neurones in the rat dorsal raphé nucleus in vitro.
    Pinnock RD
    Brain Res; 1992 Jun; 583(1-2):237-46. PubMed ID: 1354563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kappa opioid receptor activation depresses excitatory synaptic input to rat locus coeruleus neurons in vitro.
    McFadzean I; Lacey MG; Hill RG; Henderson G
    Neuroscience; 1987 Jan; 20(1):231-9. PubMed ID: 3031541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by opioids acting on mu-receptors of GABAergic and glutamatergic postsynaptic potentials in single rat periaqueductal gray neurones in vitro.
    Chieng B; Christie MJ
    Br J Pharmacol; 1994 Sep; 113(1):303-9. PubMed ID: 7812626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid-glutamate interactions in rat locus coeruleus neurons.
    Oleskevich S; Clements JD; Williams JT
    J Neurophysiol; 1993 Sep; 70(3):931-7. PubMed ID: 7693886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa-selective agonists decrease postsynaptic potentials and calcium components of action potentials in the supraoptic nucleus of rat hypothalamus in vitro.
    Inenaga K; Nagatomo T; Nakao K; Yanaihara N; Yamashita H
    Neuroscience; 1994 Jan; 58(2):331-40. PubMed ID: 7908725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid peptides reduce synaptic transmission in the nucleus accumbens.
    Yuan XR; Madamba S; Siggins GR
    Neurosci Lett; 1992 Jan; 134(2):223-8. PubMed ID: 1317025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid actions on neurons of rat lateral amygdala in vitro.
    Sugita S; North RA
    Brain Res; 1993 May; 612(1-2):151-5. PubMed ID: 8101129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different profile of electrocortical power spectrum changes after micro-infusion into the locus coeruleus of selective agonists at various opioid receptor subtypes in rats.
    Bagetta G; De Sarro GB; Sakurada S; Rispoli V; Nisticò G
    Br J Pharmacol; 1990 Nov; 101(3):655-61. PubMed ID: 1963804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric effects of mu-, delta- and kappa-opioid receptor agonists on brainstem unitary responses in the neonatal rat.
    Yuan CS
    Eur J Pharmacol; 1996 Oct; 314(1-2):27-32. PubMed ID: 8957215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of endomorphin on substantia gelatinosa neurons in rat spinal cord slices.
    Wu SY; Ohtubo Y; Brailoiu GC; Dun NJ
    Br J Pharmacol; 2003 Nov; 140(6):1088-96. PubMed ID: 14530213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
    Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of mu and delta opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus in vitro.
    Lupica CR; Proctor WR; Dunwiddie TV
    Brain Res; 1992 Oct; 593(2):226-38. PubMed ID: 1360320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kappa-/mu-receptor interactions in the opioid control of the in vivo release of substance P-like material from the rat spinal cord.
    Collin E; Mauborgne A; Bourgoin S; Mantelet S; Ferhat L; Hamon M; Cesselin F
    Neuroscience; 1992 Nov; 51(2):347-55. PubMed ID: 1281527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxytryptamine-induced excitatory postsynaptic currents in neocortical layer V pyramidal cells: suppression by mu-opiate receptor activation.
    Marek GJ; Aghajanian GK
    Neuroscience; 1998 Sep; 86(2):485-97. PubMed ID: 9881863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bremazocine differentially antagonizes responses to selective mu and delta opioid receptor agonists in rat hippocampus.
    Dunwiddie TV; Johnson KJ; Proctor WR
    Br J Pharmacol; 1987 Jul; 91(3):523-30. PubMed ID: 3038241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular mechanisms of opioid tolerance: studies in single brain neurons.
    Christie MJ; Williams JT; North RA
    Mol Pharmacol; 1987 Nov; 32(5):633-8. PubMed ID: 2824980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioidergic modulation of voltage-activated K+ currents in magnocellular neurons of the supraoptic nucleus in rat.
    Müller W; Hallermann S; Swandulla D
    J Neurophysiol; 1999 Apr; 81(4):1617-25. PubMed ID: 10200198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptic potentials in rat locus coeruleus neurones.
    Cherubini E; North RA; Williams JT
    J Physiol; 1988 Dec; 406():431-42. PubMed ID: 2908183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.